Paper36958539
Integration of miRNA's theranostic potential with nanotechnology: Promises and challenges for Parkinson's disease therapeutics.
Tryphena KP and 6 others. Mech Ageing Dev, 2023. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Integration of miRNA's theranostic potential with nanotechnology: Promises and challenges for Parkinson's disease therapeutics. Papers, record 36958539. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36958539
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Integration of miRNA's theranostic potential with nanotechnology: Promises and challenges for Parkinson's disease therapeutics.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Parkinson Disease | Major topic |
| Humans | |
| Precision Medicine | |
| Brain | |
| Blood-Brain Barrier |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42653169 | Theranostic Innovative Strategies for Brain Diseases: New Insights on Neurovascular Unit-Associated Pathological Changes in Neurodegenerative Disorders and Aging. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653169 | PubMed |
| 42204625 | MicroRNA-7: a versatile player and core target in brain disorders. | J Transl Med | 2026 | https://conductscience.org/library/papers/42204625 | PubMed |
| 41296066 | Non-coding RNAs in Parkinson's Disease: Pathogenesis, Exosomes, and Therapeutic Horizons. | Cell Mol Neurobiol | 2025 | https://conductscience.org/library/papers/41296066 | PubMed |
| 41204267 | Biomimetic nanodelivery system with simultaneous blood-brain barrier-crossing and neuroprotective abilities for anti-parkinsonian therapy. | Chin Med | 2025 | https://conductscience.org/library/papers/41204267 | PubMed |
| 40587016 | Genetic variants in oncogenic miRNA and 3' untranslated region of tumor suppressor genes: emerging insight into cancer genetics. | Med Oncol | 2025 | https://conductscience.org/library/papers/40587016 | PubMed |
| 40227305 | Quercetin loaded-magnetic zeolite nano-composite material and evaluate its anti-cancer effect. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40227305 | PubMed |
| 40100493 | New Insights on the Potential Role of Pyroptosis in Parkinson's Neuropathology and Therapeutic Targeting of NLRP3 Inflammasome with Recent Advances in Nanoparticle-Based miRNA Therapeutics. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40100493 | PubMed |
| 40085354 | Neurotoxic Effects of Atrazine on Dopaminergic System via miRNAs and Energy-Sensing Pathways. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40085354 | PubMed |
| 40056236 | LncRNAs Orchestrating Neuroinflammation: A Comprehensive Review. | Cell Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40056236 | PubMed |
| 39695016 | MicroRNA signatures in neuroplasticity, neuroinflammation and neurotransmission in association with depression. | J Physiol Biochem | 2025 | https://conductscience.org/library/papers/39695016 | PubMed |
| 39604129 | Effect of Transferrin-Modified Fe3O4 Nanoparticle Targeted Delivery miR-15a-5p Combined With Photothermal Therapy on Lung Cancer. | Thorac Cancer | 2025 | https://conductscience.org/library/papers/39604129 | PubMed |
| 39514132 | Mitophagy Unveiled: Exploring the Nexus of Mitochondrial Health and Neuroendocrinopathy. | J Mol Neurosci | 2024 | https://conductscience.org/library/papers/39514132 | PubMed |
| 39223566 | Diagnostic value of miR-34a in Mycoplasma pneumoniae pneumonia in children and its correlation with rehabilitation effect. | J Cardiothorac Surg | 2024 | https://conductscience.org/library/papers/39223566 | PubMed |
| 39162871 | MicroRNAs Modulating Neuroinflammation in Parkinson's disease. | Inflammation | 2025 | https://conductscience.org/library/papers/39162871 | PubMed |
| 38800624 | Mitochondria-Associated MicroRNAs and Parkinson's Disease. | Neurosci Insights | 2024 | https://conductscience.org/library/papers/38800624 | PubMed |
| 38346718 | Calcitriol restrains microglial M1 polarization and alleviates dopaminergic degeneration in hemiparkinsonian mice by boosting regulatory T-cell expansion. | Brain Behav | 2024 | https://conductscience.org/library/papers/38346718 | PubMed |
| 38010378 | Deeper insight into ferroptosis: association with Alzheimer's, Parkinson's disease, and brain tumors and their possible treatment by nanomaterials induced ferroptosis. | Redox Rep | 2023 | https://conductscience.org/library/papers/38010378 | PubMed |
| 37814337 | The complexity of nicotinamide adenine dinucleotide (NAD), hypoxic, and aryl hydrocarbon receptor cell signaling in chronic kidney disease. | J Transl Med | 2023 | https://conductscience.org/library/papers/37814337 | PubMed |
| 37541971 | PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson's disease in rats. | Inflammopharmacology | 2024 | https://conductscience.org/library/papers/37541971 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36958539
GET https://conductscience.org/api/papers/v1/36958539/authors